Article
MBL2 and hepatitis C virus infection among injection drug users.
BMC infectious diseases - 1 May 2008
Brown Elizabeth E, Zhang Mingdong, Zarin-Pass Rebecca, Bernig Toralf, Tseng Fan-Chen, Xiao Nianqing, Yeager Meredith, Edlin Brian R, Chanock Stephen J, O'Brien Thomas R
Abstract excerpt
BACKGROUND: Genetic variations in MBL2 that reduce circulating levels and alter functional properties of the mannose binding lectin (MBL) have been associated with many autoimmune and infectious diseases. We examined whether MBL2 variants influence the outcome of hepatitis C virus (HCV) infection. METHODS: Participants were enrolled in the Urban Health Study of San Francisco Bay area injection drug users (IDU)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
